CNTB: Connect Biopharma Holdings Limited - American Depositary Shares

2.10 USD 0.26 (14.13%)

Setor: Cuidados de saúde Base: US Dollar Moeda de lucro: US Dollar

A taxa do CNTB para hoje mudou para 14.13%. Paralelamente, o preço mais baixo no mercado atingiu 1.73 e o mais alto foi 2.11.

Veja a dinâmica do par de moedas Connect Biopharma Holdings Limited - American Depositary Shares. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.

Tela cheia

CNTB Notícias

Zacks 16:00 What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now?
Investing 13:45 Connect Biopharma stock rating reiterated as Outperform by Northland
Investing 13:32 Connect Biopharma appoints Jim Schoeneck to board of directors
Investing 13:17 Connect Biopharma appoints James A. Schoeneck to board of directors
Investing 13:52 Connect Biopharma stock rises after announcing plan to terminate ADR program
Investing 13:16 Connect Biopharma to terminate ADR program, list ordinary shares
Investing 13:31 Connect Biopharma regains Nasdaq compliance with minimum bid price rule
Investing 13:07 Connect Biopharma regains Nasdaq compliance with $1 minimum bid price
Investing 13:13 Connect Biopharma’s partner submits new drug application in China
Investing 13:05 Connect Biopharma reports positive data for asthma treatment
Investing 13:52 Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
Investing 13:40 Connect Biopharma to Present at Two Upcoming Investor Conferences in June
Investing 13:32 Connect Biopharma Presents Data Supporting Development of Rademikibart at the American Thoracic Society (ATS) 2025 International Conference
Investing 13:52 Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update
Investing 13:27 Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD

Faixa diária

1.73 2.11

Faixa anual

0.51 2.86

Fechamento anterior: 1.75
Open: 1.84

Bid: 2.10
Ask: 2.40

Low: 1.73
High: 2.11

Volume: 450

Mudança diária: 14.13%
Mudança mensal: 101.92%

Mudança de 6 meses: 116.49%
Mudança anual: 77.97%

31 julho, quinta-feira